Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Go back to Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.35 +0.12 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.23 | 52 Week High | $9.23 | |||
| Open | $9.35 | 52 Week Low | $1.16 | |||
| Day High | $9.41 | P/E | N/A | |||
| Day Low | $9.16 | EPS | $-0.30 | |||
| Volume | 2,848,478 | |||||
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.35 +0.12 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.23 | 52 Week High | $9.23 | |||
| Open | $9.35 | 52 Week Low | $1.16 | |||
| Day High | $9.41 | P/E | N/A | |||
| Day Low | $9.16 | EPS | $-0.30 | |||
| Volume | 2,848,478 | |||||

